Skip to content

Effects of Physical Training Convergence Forest Healing Program on Mental and Physical Health and Cognitive Ability of the Elderly

Effects of Physical Training Convergence Forest Healing Program on Mental and Physical Health and Cognitive Ability of the Elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011558
Enrollment
48
Registered
2026-01-31
Start date
2023-10-02
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : Intervention 1. Control Group (with Metabolic Syndrome) Participants with metabolic syndrome will maintain their usual daily activities for 10 weeks, and no separate exercise interventio

Sponsors

Kangwon National University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Minimum age 65, maximum age 78 (1) Elderly individuals aged 65 and older who are able to participate in regular exercise (2) Individuals who voluntarily consent to participate in the study (3) Individuals with metabolic syndrome (Group 2)

Exclusion criteria

Exclusion criteria: (1) Individuals who have been diagnosed with a musculoskeletal disorder within the past six months and are unable to participate in walking or exercise programs, (2) Individuals with severe cardiovascular disease who are unable to participate in resistance exercise programs, (3) Individuals who are unable to perform daily activities independently due to depression, anxiety, insomnia, etc., (4) Individuals currently taking blood glucose-lowering medications, (5) Individuals who are currently losing weight or planning to lose weight, or who are already participating in a planned exercise program at least twice a week, (6) Individuals who are deemed unsuitable for participation in this clinical trial by the researcher or attending physician due to other factors that may affect the results of this clinical trial. However, if individuals are taking blood pressure medication or lipid-lowering medication (for hyperlipidemia), participation is permitted if the medication schedule remains consistent throughout the study period.

Design outcomes

Primary

MeasureTime frame
Body compositon(Height, Muscle mass, Fat mass, Fat percent);Neurokines;Physical fitness ;Metabolic syndrome indicators(ATP3);FGF-21;Adipokines

Secondary

MeasureTime frame
Cognitive function test

Countries

Korea, Republic of

Contacts

Public ContactDeokhwa Jeong

Kangwon National University

93deokgoo@kangwon.ac.kr+82-33-250-6780

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 7, 2026